{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import re, os, sys, difflib\n",
    "from com.ibm.watson.datasource.clinicaltrials import ClinicalStudy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Inclusion Criteria:\n",
      "\n",
      "          -  Male or female aged ≥ 18 years\n",
      "\n",
      "          -  Histological or cytological confirmed metastatic colorectal cancer\n",
      "\n",
      "          -  Written documentation of KRAS wild-type status and BRAFV600-mutation with RNF43\n",
      "             mutation and/or RSPO fusion\n",
      "\n",
      "          -  Progression of disease after at least one prior standard of care regimen or\n",
      "             intolerant to irinotecan based regimens\n",
      "\n",
      "          -  Availability of a representative tumor specimen (primary or metastatic, archival or\n",
      "             newly obtained)\n",
      "\n",
      "          -  Measurable disease as per RECIST v1.1\n",
      "\n",
      "          -  Eastern cooperative oncology group (ECOG) performance status ≤ 2\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          -  Phase II only: Prior treatment with RAF inhibitors, Wnt pathway inhibitors,\n",
      "             cetuximab, panitumumab, and/or other EGFR inhibitors\n",
      "\n",
      "          -  Symptomatic brain metastasis. Patients previously treated or untreated for these\n",
      "             conditions that are asymptomatic in the absence of corticosteroid and anti-epileptic\n",
      "             therapy are allowed to enroll\n",
      "\n",
      "          -  Current treatment with medications or consuming foods that are strong inhibitors or\n",
      "             inducers of CYP3A4/5 or herbal medications and that cannot be discontinued at least\n",
      "             one week prior to the start of treatment.\n",
      "\n",
      "          -  Symptomatic or untreated leptomeningeal disease\n",
      "\n",
      "          -  Acute or chronic pancreatitis\n",
      "\n",
      "          -  Clinically significant cardiac disease\n",
      "\n",
      "          -  Patients with any of the following laboratory values at Screening/baseline\n",
      "\n",
      "               -  Absolute neutrophil count (ANC) <1,500/mm3\n",
      "\n",
      "               -  Platelets < 100,000/mm3\n",
      "\n",
      "               -  Hemoglobin < 9.0 g/dL\n",
      "\n",
      "               -  Serum creatinine >1.5 x ULN or calculated or directly measured CrCl < 50% lower\n",
      "                  limit of normal\n",
      "\n",
      "               -  Serum total bilirubin >1.5 x ULN\n",
      "\n",
      "               -  AST/SGOT and/or ALT/SGPT > 2.5 x ULN, (> 5 x ULN if liver metastases present)\n",
      "\n",
      "          -  Patients with impaired hepatic function as defined by Childs-Pugh class B or C\n",
      "\n",
      "          -  Impairment of gastrointestinal (GI) function or GI disease that may significantly\n",
      "             alter the absorption of oral WNT974/LGX818\n",
      "\n",
      "        Other protocol-defined inclusion/exclusion criteria may apply\n"
     ]
    }
   ],
   "source": [
    "nct_id = \"NCT02278133\"\n",
    "cs = ClinicalStudy(nct_id)\n",
    "cs.get()\n",
    "raw_text = cs._xml.eligibility.criteria.textblock.strip()\n",
    "print raw_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Inclusion Criteria:. \n",
      "Male or female aged ≥ 18 years. \n",
      "Histological or cytological confirmed metastatic colorectal cancer. \n",
      "Written documentation of KRAS wild-type status and BRAFV600-mutation with RNF43 mutation and / or RSPO fusion. \n",
      "Progression of disease after at least one prior standard of care regimen or intolerant to irinotecan based regimens. \n",
      "Availability of a representative tumor specimen (primary or metastatic, archival or newly obtained). \n",
      "Measurable disease as per RECIST v1.1. \n",
      "Eastern cooperative oncology group (ECOG) performance status ≤ 2. \n",
      "Exclusion Criteria:. \n",
      "Phase II only: Prior treatment with RAF inhibitors, Wnt pathway inhibitors, cetuximab, panitumumab, and / or other EGFR inhibitors. \n",
      "Symptomatic brain metastasis. Patients previously treated or untreated for these conditions that are asymptomatic in the absence of corticosteroid and anti-epileptic therapy are allowed to enroll. \n",
      "Current treatment with medications or consuming foods that are strong inhibitors or inducers of CYP3A4 / 5 or herbal medications and that cannot be discontinued at least one week prior to the start of treatment.\n",
      "Symptomatic or untreated leptomeningeal disease. \n",
      "Acute or chronic pancreatitis. \n",
      "Clinically significant cardiac disease. \n",
      "Patients with any of the following laboratory values at Screening / baseline. \n",
      "Absolute neutrophil count (ANC) <1,500 / mm3. \n",
      "Platelets < 100,000 / mm3. \n",
      "Hemoglobin < 9.0 g / dL. \n",
      "Serum creatinine >1.5 x ULN or calculated or directly measured CrCl < 50% lower limit of normal. \n",
      "Serum total bilirubin >1.5 x ULN. \n",
      "AST / SGOT and / or ALT / SGPT > 2.5 x ULN, (> 5 x ULN if liver metastases present). \n",
      "Patients with impaired hepatic function as defined by Childs-Pugh class B or C. \n",
      "Impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of oral WNT974 / LGX818. \n",
      "Other protocol-defined inclusion / exclusion criteria may apply\n"
     ]
    }
   ],
   "source": [
    "stripped_text = open(\"/Users/singhv/dev/scripts/temp/NCT02278133.txt\").read().decode(\"utf-8\")\n",
    "print stripped_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "  equal a[0:19] (Inclusion Criteria:) b[0:19] (Inclusion Criteria:)\n",
      "replace a[19:34] (\n",
      "\n",
      "          -  ) b[19:22] (. \n",
      ")\n",
      "  equal a[34:64] (Male or female aged ≥ 18 years) b[22:52] (Male or female aged ≥ 18 years)\n",
      "replace a[64:79] (\n",
      "\n",
      "          -  ) b[52:55] (. \n",
      ")\n",
      "  equal a[79:145] (Histological or cytological confirmed metastatic colorectal cancer) b[55:121] (Histological or cytological confirmed metastatic colorectal cancer)\n",
      "replace a[145:160] (\n",
      "\n",
      "          -  ) b[121:124] (. \n",
      ")\n",
      "  equal a[160:239] (Written documentation of KRAS wild-type status and BRAFV600-mutation with RNF43) b[124:203] (Written documentation of KRAS wild-type status and BRAFV600-mutation with RNF43)\n",
      "replace a[239:265] (\n",
      "             mutation and) b[203:217] ( mutation and )\n",
      "  equal a[265:266] (/) b[217:218] (/)\n",
      " insert a[266:266] () b[218:219] ( )\n",
      "  equal a[266:280] (or RSPO fusion) b[219:233] (or RSPO fusion)\n",
      "replace a[280:295] (\n",
      "\n",
      "          -  ) b[233:236] (. \n",
      ")\n",
      "  equal a[295:370] (Progression of disease after at least one prior standard of care regimen or) b[236:311] (Progression of disease after at least one prior standard of care regimen or)\n",
      " delete a[370:383] (\n",
      "            ) b[311:311] ()\n",
      "  equal a[383:423] ( intolerant to irinotecan based regimens) b[311:351] ( intolerant to irinotecan based regimens)\n",
      "replace a[423:438] (\n",
      "\n",
      "          -  ) b[351:354] (. \n",
      ")\n",
      "  equal a[438:521] (Availability of a representative tumor specimen (primary or metastatic, archival or) b[354:437] (Availability of a representative tumor specimen (primary or metastatic, archival or)\n",
      " delete a[521:534] (\n",
      "            ) b[437:437] ()\n",
      "  equal a[534:550] ( newly obtained)) b[437:453] ( newly obtained))\n",
      "replace a[550:565] (\n",
      "\n",
      "          -  ) b[453:456] (. \n",
      ")\n",
      "  equal a[565:602] (Measurable disease as per RECIST v1.1) b[456:493] (Measurable disease as per RECIST v1.1)\n",
      "replace a[602:617] (\n",
      "\n",
      "          -  ) b[493:496] (. \n",
      ")\n",
      "  equal a[617:681] (Eastern cooperative oncology group (ECOG) performance status ≤ 2) b[496:560] (Eastern cooperative oncology group (ECOG) performance status ≤ 2)\n",
      "replace a[681:691] (\n",
      "\n",
      "        ) b[560:563] (. \n",
      ")\n",
      "  equal a[691:710] (Exclusion Criteria:) b[563:582] (Exclusion Criteria:)\n",
      "replace a[710:725] (\n",
      "\n",
      "          -  ) b[582:585] (. \n",
      ")\n",
      "  equal a[725:800] (Phase II only: Prior treatment with RAF inhibitors, Wnt pathway inhibitors,) b[585:660] (Phase II only: Prior treatment with RAF inhibitors, Wnt pathway inhibitors,)\n",
      " delete a[800:813] (\n",
      "            ) b[660:660] ()\n",
      "  equal a[813:841] ( cetuximab, panitumumab, and) b[660:688] ( cetuximab, panitumumab, and)\n",
      " insert a[841:841] () b[688:689] ( )\n",
      "  equal a[841:842] (/) b[689:690] (/)\n",
      " insert a[842:842] () b[690:691] ( )\n",
      "  equal a[842:866] (or other EGFR inhibitors) b[691:715] (or other EGFR inhibitors)\n",
      "replace a[866:878] (\n",
      "\n",
      "          ) b[715:873] (. \n",
      "Symptomatic brain metastasis. Patients previously treated or untreated for these conditions that are asymptomatic in the absence of corticosteroid and anti)\n",
      "  equal a[878:879] (-) b[873:874] (-)\n",
      "replace a[879:1072] (  Symptomatic brain metastasis. Patients previously treated or untreated for these\n",
      "             conditions that are asymptomatic in the absence of corticosteroid and anti-epileptic\n",
      "            ) b[874:883] (epileptic)\n",
      "  equal a[1072:1102] ( therapy are allowed to enroll) b[883:913] ( therapy are allowed to enroll)\n",
      "replace a[1102:1117] (\n",
      "\n",
      "          -  ) b[913:916] (. \n",
      ")\n",
      "  equal a[1117:1200] (Current treatment with medications or consuming foods that are strong inhibitors or) b[916:999] (Current treatment with medications or consuming foods that are strong inhibitors or)\n",
      " delete a[1200:1213] (\n",
      "            ) b[999:999] ()\n",
      "  equal a[1213:1232] ( inducers of CYP3A4) b[999:1018] ( inducers of CYP3A4)\n",
      " insert a[1232:1232] () b[1018:1019] ( )\n",
      "  equal a[1232:1233] (/) b[1019:1020] (/)\n",
      " insert a[1233:1233] () b[1020:1021] ( )\n",
      "  equal a[1233:1297] (5 or herbal medications and that cannot be discontinued at least) b[1021:1085] (5 or herbal medications and that cannot be discontinued at least)\n",
      " delete a[1297:1310] (\n",
      "            ) b[1085:1085] ()\n",
      "  equal a[1310:1353] ( one week prior to the start of treatment.\n",
      ") b[1085:1128] ( one week prior to the start of treatment.\n",
      ")\n",
      " delete a[1353:1367] (\n",
      "          -  ) b[1128:1128] ()\n",
      "  equal a[1367:1414] (Symptomatic or untreated leptomeningeal disease) b[1128:1175] (Symptomatic or untreated leptomeningeal disease)\n",
      "replace a[1414:1429] (\n",
      "\n",
      "          -  ) b[1175:1178] (. \n",
      ")\n",
      "  equal a[1429:1458] (Acute or chronic pancreatitis) b[1178:1207] (Acute or chronic pancreatitis)\n",
      "replace a[1458:1473] (\n",
      "\n",
      "          -  ) b[1207:1210] (. \n",
      ")\n",
      "  equal a[1473:1511] (Clinically significant cardiac disease) b[1210:1248] (Clinically significant cardiac disease)\n",
      "replace a[1511:1526] (\n",
      "\n",
      "          -  ) b[1248:1251] (. \n",
      ")\n",
      "  equal a[1526:1591] (Patients with any of the following laboratory values at Screening) b[1251:1316] (Patients with any of the following laboratory values at Screening)\n",
      " insert a[1591:1591] () b[1316:1317] ( )\n",
      "  equal a[1591:1592] (/) b[1317:1318] (/)\n",
      "replace a[1592:1620] (baseline\n",
      "\n",
      "               -  ) b[1318:1330] ( baseline. \n",
      ")\n",
      "  equal a[1620:1658] (Absolute neutrophil count (ANC) <1,500) b[1330:1368] (Absolute neutrophil count (ANC) <1,500)\n",
      " insert a[1658:1658] () b[1368:1369] ( )\n",
      "  equal a[1658:1659] (/) b[1369:1370] (/)\n",
      " insert a[1659:1659] () b[1370:1371] ( )\n",
      "  equal a[1659:1662] (mm3) b[1371:1374] (mm3)\n",
      "replace a[1662:1682] (\n",
      "\n",
      "               -  ) b[1374:1377] (. \n",
      ")\n",
      "  equal a[1682:1701] (Platelets < 100,000) b[1377:1396] (Platelets < 100,000)\n",
      " insert a[1701:1701] () b[1396:1397] ( )\n",
      "  equal a[1701:1702] (/) b[1397:1398] (/)\n",
      " insert a[1702:1702] () b[1398:1399] ( )\n",
      "  equal a[1702:1705] (mm3) b[1399:1402] (mm3)\n",
      "replace a[1705:1725] (\n",
      "\n",
      "               -  ) b[1402:1405] (. \n",
      ")\n",
      "  equal a[1725:1743] (Hemoglobin < 9.0 g) b[1405:1423] (Hemoglobin < 9.0 g)\n",
      " insert a[1743:1743] () b[1423:1424] ( )\n",
      "  equal a[1743:1744] (/) b[1424:1425] (/)\n",
      " insert a[1744:1744] () b[1425:1426] ( )\n",
      "  equal a[1744:1746] (dL) b[1426:1428] (dL)\n",
      "replace a[1746:1766] (\n",
      "\n",
      "               -  ) b[1428:1431] (. \n",
      ")\n",
      "  equal a[1766:1845] (Serum creatinine >1.5 x ULN or calculated or directly measured CrCl < 50% lower) b[1431:1510] (Serum creatinine >1.5 x ULN or calculated or directly measured CrCl < 50% lower)\n",
      "replace a[1845:1899] (\n",
      "                  limit of normal\n",
      "\n",
      "               -  ) b[1510:1529] ( limit of normal. \n",
      ")\n",
      "  equal a[1899:1931] (Serum total bilirubin >1.5 x ULN) b[1529:1561] (Serum total bilirubin >1.5 x ULN)\n",
      "replace a[1931:1951] (\n",
      "\n",
      "               -  ) b[1561:1564] (. \n",
      ")\n",
      "  equal a[1951:1954] (AST) b[1564:1567] (AST)\n",
      " insert a[1954:1954] () b[1567:1568] ( )\n",
      "  equal a[1954:1955] (/) b[1568:1569] (/)\n",
      " insert a[1955:1955] () b[1569:1570] ( )\n",
      "  equal a[1955:1963] (SGOT and) b[1570:1578] (SGOT and)\n",
      " insert a[1963:1963] () b[1578:1579] ( )\n",
      "  equal a[1963:1964] (/) b[1579:1580] (/)\n",
      " insert a[1964:1964] () b[1580:1581] ( )\n",
      "  equal a[1964:1970] (or ALT) b[1581:1587] (or ALT)\n",
      " insert a[1970:1970] () b[1587:1588] ( )\n",
      "  equal a[1970:1971] (/) b[1588:1589] (/)\n",
      " insert a[1971:1971] () b[1589:1590] ( )\n",
      "  equal a[1971:2028] (SGPT > 2.5 x ULN, (> 5 x ULN if liver metastases present)) b[1590:1647] (SGPT > 2.5 x ULN, (> 5 x ULN if liver metastases present))\n",
      "replace a[2028:2043] (\n",
      "\n",
      "          -  ) b[1647:1650] (. \n",
      ")\n",
      "  equal a[2043:2121] (Patients with impaired hepatic function as defined by Childs-Pugh class B or C) b[1650:1728] (Patients with impaired hepatic function as defined by Childs-Pugh class B or C)\n",
      "replace a[2121:2136] (\n",
      "\n",
      "          -  ) b[1728:1731] (. \n",
      ")\n",
      "  equal a[2136:2217] (Impairment of gastrointestinal (GI) function or GI disease that may significantly) b[1731:1812] (Impairment of gastrointestinal (GI) function or GI disease that may significantly)\n",
      " delete a[2217:2230] (\n",
      "            ) b[1812:1812] ()\n",
      "  equal a[2230:2266] ( alter the absorption of oral WNT974) b[1812:1848] ( alter the absorption of oral WNT974)\n",
      " insert a[2266:2266] () b[1848:1849] ( )\n",
      "  equal a[2266:2267] (/) b[1849:1850] (/)\n",
      " insert a[2267:2267] () b[1850:1851] ( )\n",
      "  equal a[2267:2273] (LGX818) b[1851:1857] (LGX818)\n",
      "replace a[2273:2283] (\n",
      "\n",
      "        ) b[1857:1860] (. \n",
      ")\n",
      "  equal a[2283:2315] (Other protocol-defined inclusion) b[1860:1892] (Other protocol-defined inclusion)\n",
      " insert a[2315:2315] () b[1892:1893] ( )\n",
      "  equal a[2315:2316] (/) b[1893:1894] (/)\n",
      " insert a[2316:2316] () b[1894:1895] ( )\n",
      "  equal a[2316:2344] (exclusion criteria may apply) b[1895:1923] (exclusion criteria may apply)\n"
     ]
    }
   ],
   "source": [
    "seq_matcher = difflib.SequenceMatcher()\n",
    "seq_matcher.set_seq1(raw_text)\n",
    "seq_matcher.set_seq2(stripped_text)\n",
    "for tag, i1, i2, j1, j2 in seq_matcher.get_opcodes():\n",
    "    print (\"%7s a[%d:%d] (%s) b[%d:%d] (%s)\" % (tag, i1, i2, raw_text[i1:i2], j1, j2, stripped_text[j1:j2]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
